222 related articles for article (PubMed ID: 35386310)
1. Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy.
Wang B; Tang M; Yuan Z; Li Z; Hu B; Bai X; Chu J; Xu X; Zhang XQ
Bioact Mater; 2022 Oct; 16():232-248. PubMed ID: 35386310
[TBL] [Abstract][Full Text] [Related]
2. Rational design of engineered H-ferritin nanoparticles with improved siRNA delivery efficacy across an
Yuan Z; Wang B; Teng Y; Ho W; Hu B; Boakye-Yiadom KO; Xu X; Zhang XQ
Nanoscale; 2022 May; 14(17):6449-6464. PubMed ID: 35416195
[TBL] [Abstract][Full Text] [Related]
3. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
4. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.
Fan K; Jia X; Zhou M; Wang K; Conde J; He J; Tian J; Yan X
ACS Nano; 2018 May; 12(5):4105-4115. PubMed ID: 29608290
[TBL] [Abstract][Full Text] [Related]
5. Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment.
Liu W; Lin Q; Fu Y; Huang S; Guo C; Li L; Wang L; Zhang Z; Zhang L
J Control Release; 2020 Jul; 323():191-202. PubMed ID: 31838201
[TBL] [Abstract][Full Text] [Related]
6. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
7. The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood-brain barrier and attenuates their targeting ability to brain tumor.
Xiao W; Wang Y; Zhang H; Liu Y; Xie R; He X; Zhou Y; Liang L; Gao H
Biomaterials; 2021 Jul; 274():120888. PubMed ID: 34029915
[TBL] [Abstract][Full Text] [Related]
8. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
9. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
10. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeting biomimetic delivery for anti-glioma activity
Zhao P; Wang Y; Kang X; Wu A; Yin W; Tang Y; Wang J; Zhang M; Duan Y; Huang Y
Chem Sci; 2018 Mar; 9(10):2674-2689. PubMed ID: 29732051
[TBL] [Abstract][Full Text] [Related]
12. Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
Cui Y; Zhang M; Zeng F; Jin H; Xu Q; Huang Y
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32159-32169. PubMed ID: 27808492
[TBL] [Abstract][Full Text] [Related]
13. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).
Kumari S; Ahsan SM; Kumar JM; Kondapi AK; Rao NM
Sci Rep; 2017 Jul; 7(1):6602. PubMed ID: 28747713
[TBL] [Abstract][Full Text] [Related]
14. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
15. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
16. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
Ju X; Miao T; Chen H; Ni J; Han L
Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.
Wang S; Reinhard S; Li C; Qian M; Jiang H; Du Y; Lächelt U; Lu W; Wagner E; Huang R
Mol Ther; 2017 Jul; 25(7):1556-1566. PubMed ID: 28502470
[TBL] [Abstract][Full Text] [Related]
19. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
20. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
